Overland Park, KS, United States of America

Ramune Marija Cobb


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 48(Granted Patents)


Location History:

  • New South Wales, AU (1999)
  • Overland Park, KS (US) (2004)

Company Filing History:


Years Active: 1999-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ramune Marija Cobb

Introduction

Ramune Marija Cobb is a notable inventor based in Overland Park, Kansas. She has made significant contributions to the field of vaccine development, holding 2 patents that focus on stable vaccine compositions for parenteral administration. Her work aims to enhance the effectiveness of vaccines in preventing various diseases in warm-blooded animals.

Latest Patents

Cobb's latest patents include innovative stable vaccine compositions that comprise a macrocyclic lactone compound, a milbemycin compound, an avermectin compound, or mixtures thereof. These compositions also contain at least one antigen, a dispersing agent, an adjuvant, a water-soluble organic solvent, and saline or water. Additionally, she has developed stable compositions that do not include an antigen. The inventions are designed to prevent or control helminthiasis, infections by acarids, arthropod endo- and ectoparasites, as well as bacterial and viral diseases in warm-blooded animals through parenteral administration.

Career Highlights

Cobb is currently associated with the American Cyanamid Company, where she continues to innovate in the field of veterinary medicine. Her research and inventions have the potential to significantly impact animal health and welfare.

Collaborations

Cobb collaborates with Christopher Leigh Schwartzkoff, who is also a key figure in her research endeavors. Their partnership enhances the development of effective vaccine solutions.

Conclusion

Ramune Marija Cobb's contributions to vaccine technology demonstrate her commitment to improving animal health through innovative solutions. Her patents reflect a deep understanding of the complexities involved in vaccine formulation and application.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…